Cardiovascular · InjectableSafety Signalregulatorynear-term

American Regent Issues Nationwide Recall of Papaverine Hydrochloride Injection Due to Contamination

Importance8/ 10

ActionMonitor

AutoResearch

Multi-agent research across ingested FDA, EMA, MHRA, PMDA, PubMed, ClinicalTrials.gov, company documents, and Humanexa signals.

Last run 7/28/2026, 6:01:42 AM

Assessment confidence: 63% · The main uncertainty is timing and magnitude of competitive and regulatory follow-through.

Executive Thesis

The recall of Papaverine Hydrochloride Injection due to contamination poses significant safety concerns and may disrupt market availability. This situation necessitates close monitoring of regulatory responses and competitor strategies to mitigate potential market share impacts. Regulatory context from FDA (American Regent, Inc.) supports the near-term read. Assessment grounded in 23 ranked evidence items (9 high-relevance).

Strategic Assessment

Portfolio teams should assess the impact of this recall on market share and consider strategies to mitigate supply disruptions. The strongest clinical anchor is Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine. In Cardiovascular · Injectable, 7 regulatory and 3 competitive items passed relevance filtering for Papaverine Hydrochloride Injection.

Competitive Pressure

The most relevant competitive pressure comes from Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025 (Bristol Myers Squibb) — mechanism alignment (io ); sponsor/company relevance (bristol myers squibb). Secondary pressure from FDA Grants Approval for Dexmedetomidine Hydrochloride by Baxter Healthcare.

Regulatory Outlook

Regulatory risk is concentrated around American Regent, Inc. Entity match (papaverine hydrochloride injection). The contamination issue raises serious compliance concerns, which may lead to increased scrutiny from regulatory bodies and potential implications for future approvals.

Key Risks

Elevated high regulatory exposure for Papaverine Hydrochloride Injection could delay market entry or constrain labeling if agency review intensifies.
Signal severity is high — leadership review is warranted.

Key Opportunities

The recall could lead to reduced availability of Papaverine Hydrochloride, potentially allowing competitors to capture market share and affecting revenue streams for American Regent.
Upside for Papaverine Hydrochloride Injection may improve if A Study Comparing Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy Participants (ClinicalTrials.gov) delivers favorable follow-through.
Khong Guan Corporation (Union City, CA) is recalling specific lots of “Glutinous Rice Balls with Black Sesame Filling” and “Black & White Glutinous Rice Balls with Black Sesame Filling” in their recall expansion because they may contain undeclared peanuts.
Upside for Papaverine Hydrochloride Injection may improve if Trends in ritodrine prescriptions among pregnant women in Japan: a nationwide descriptive analysis of an administrative hospital database from 2015 to 2024. (PubMed) delivers favorable follow-through.
Immunology · JAK Inhibitors · Label Change · This label change may impact the prescribing patterns and market share of these JAK inhibitors, as safety concerns could lead to reduced usage.

What Would Change This Assessment

This becomes more urgent if Monitor for updates on the recall process and any potential regulatory actions or further recalls.
Timeline shift beyond near term would change urgency.
Outcome from Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025 would change the regulatory/clinical read.
A competitor label expansion or pivotal readout in the same sub-indication would increase competitive pressure.

Supporting Evidence

American Regent, Inc.
FDAhigh relevance
Entity match (papaverine hydrochloride injection)
FDA document
View source
Khong Guan Corporation Issues Expanded Recall of Glutinous Rice Balls With Black Sesame Filling to Include Black & White Glutinous Rice Balls With Black Sesame Filling Due to Undeclared Peanuts
FDAhigh relevance
Regulatory pathway relevance (bla)
FDA document
View source
Khong Guan Corporation Issues Recall of Glutinous Rice Balls With Black Sesame Filling Due to Undeclared Peanuts
FDAhigh relevance
Regulatory pathway relevance (bla)
FDA document
View source
BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION
FDAhigh relevance
Moderate corpus alignment
FDA document
View source
Beekeeper’s Naturals Issues Voluntary Nationwide Recall of Beekeeper’s Naturals Saline Nasal Spray Sold Through Amazon Due to Microbial Contamination
FDAhigh relevance
Moderate corpus alignment
FDA document
View source
Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP
FDAhigh relevance
Moderate corpus alignment
FDA document
View source
Convenience Kit Correction: Arrow International Issues Correction for Convenience Kits Containing Recalled Huons Lidocaine and Bupivacaine and Saline
FDAmedium relevance
Moderate corpus alignment
FDA document
View source

Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.
ClinicalTrials.govhigh relevance
Mechanism alignment (IO )
FDA document
View source
A Study Comparing Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy Participants
ClinicalTrials.govhigh relevance
Mechanism alignment (IO )
FDA document
View source
Physical Fitness, Cardiovascular and Brain Health
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source
A Study to Investigate Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in Participants With Schizophrenia
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source
Enhancing Smoking Cessation for African American People Everywhere
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source
A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and No
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source
Vibratory Anesthesia on Pain Following Corticosteroid Injections
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source

Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025
Bristol Myers Squibbhigh relevance
Mechanism alignment (IO ); Sponsor/company relevance (Bristol Myers Squibb)
FDA document
View source
FDA Grants Approval for Dexmedetomidine Hydrochloride by Baxter Healthcare
Humanexa Signalsmedium relevance
Moderate corpus alignment
FDA Updates Boxed Warnings for JAK Inhibitors Due to Serious Risks
Humanexa Signalsmedium relevance
Moderate corpus alignment

Microneedle-based injection of Fungizone/Amphotericin B: an effective treatment for American cutaneous leishmaniasis in mice.
PubMedmedium relevance
Moderate corpus alignment
FDA document
View source
Trends in ritodrine prescriptions among pregnant women in Japan: a nationwide descriptive analysis of an administrative hospital database from 2015 to 2024.
PubMedmedium relevance
Moderate corpus alignment
FDA document
View source
Integrating machine learning and pharmacology reveals NF-κB-mediated inflammatory regulation by Shuanghuanglian injection in acute lung injury.
PubMedmedium relevance
Moderate corpus alignment
FDA document
View source
Impact of dual antiplatelet therapy duration after percutaneous coronary intervention on outcomes in acute coronary syndrome patients with and without chronic kidney disease: a nationwide cohort study
PubMedmedium relevance
Moderate corpus alignment
FDA document
View source
Optimizing estradiol serum levels for optimal skeletal and cardiovascular health during transdermal menopausal hormone therapy.
PubMedmedium relevance
Moderate corpus alignment
FDA document
View source

Regunera

Precedents · guidance

Reg

Loading regulatory precedents…

View full regulatory analysis

Competitiva

Competitors · threats

Intel

Loading competitive findings…

View full competitive analysis

Why this matters

Affected entities

Papaverine Hydrochloride Injection

Commercial impact

medium

The recall could lead to reduced availability of Papaverine Hydrochloride, potentially allowing competitors to capture market share and affecting revenue streams for American Regent.

Regulatory impact

high

The contamination issue raises serious compliance concerns, which may lead to increased scrutiny from regulatory bodies and potential implications for future approvals.

What to watch

Monitor for updates on the recall process and any potential regulatory actions or further recalls.

Recommended action

Monitor

Track for follow-up milestones; no immediate action required.